References

Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020

10.1001/jama.2024.6892 · 2024 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

State-level prevalence of cardiovascular-kidney-metabolic syndrome stages in the United States, 2011 to 2023

2025 · External reference

A social vulnerability index for disaster management

10.2202/1547-7355.1792 · 2011 · External reference

Hypertension prevalence, awareness, treatment, and control among adults age 18 and older: United States, august 2021-august 2023

2024 · External reference

Treatment of cardiometabolic risk factors among U.S. adults with cardiovascular-kidney-metabolic syndrome

10.1016/j.jacc.2026.04.031 · 2026 · External reference

Chronic kidney disease prevalence and awareness among US adults

10.1001/jamacardio.2025.4581 · 2026 · External reference

PLACES: local data for better health

10.5888/pcd19.210459 · 2022 · External reference

Social determinants of risk and outcomes for cardiovascular disease

10.1161/cir.0000000000000228 · 2015 · External reference

Unresolved reference

External reference

New creatinine- and cystatin C–based equations to estimate GFR without race

10.1056/nejmoa2102953 · 2021 · External reference

Prevalence and control of diabetes among US adults, 2013 to 2023

10.1001/jama.2024.28513 · 2025 · External reference

Development and validation of the American Heart Association’s PREVENT equations

10.1161/circulationaha.123.067626 · 2024 · External reference

KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease

2024 · External reference

Neighborhood indices, income, and cardiovascular-kidney-metabolic syndrome at the census tract level

10.1001/jamanetworkopen.2026.6019 · 2026 · External reference

Trends in prevalence, treatment, and control of cardiometabolic risk factors among adults with hypertension in the United States, 1999–2023

10.1016/j.jacc.2025.09.1607 · 2025 · External reference

Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults

10.1161/jaha.124.034996 · 2024 · External reference

Analysis of complex survey samples

10.18637/jss.v009.i08 · 2004 · External reference

Prevalence of the cardiovascular-kidney-metabolic syndrome in the United States

10.1016/j.jacc.2024.03.368 · 2024 · External reference

Unresolved reference

2017 · External reference

Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association

10.1161/cir.0000000000001184 · 2023 · External reference

2026 AHA/ACC/ADA/ASN guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome

10.1016/j.jacc.2026.03.056 · 2026 · External reference

Risk factor control in U.S. adults with cardiovascular-kidney-metabolic multimorbidity, 1999–2020

10.1016/j.jacc.2025.05.052 · 2025 · External reference

Unresolved reference

External reference

Unresolved reference

2026 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2024 · External reference

Improving blood pressure control in the United States: at the heart of million hearts 2027

10.1093/ajh/hpad029 · 2023 · External reference

Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011–2021: a representative longitudinal serial study

10.1016/j.lanwpc.2025.101474 · 2025 · External reference

Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health

10.1001/jamanetworkopen.2024.45309 · 2024 · External reference